These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 39099792)

  • 1. Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis.
    An P; Zhao Q; Hao S; Wang X; Tian J; Ma Z
    Int J Nanomedicine; 2024; 19():7631-7671. PubMed ID: 39099792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.
    Puglia C; Bonina F
    Expert Opin Drug Deliv; 2012 Apr; 9(4):429-41. PubMed ID: 22394125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
    Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
    Katare OP; Raza K; Singh B; Dogra S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanodiamond-based berberine aquasomes for enhancing penetration across epidermis to treat psoriasis.
    Kulkarni S; Prabhakar B; Shende P
    Int J Pharm; 2024 May; 656():124051. PubMed ID: 38574956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
    Gungor S; Rezigue M
    Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
    Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
    Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriol Nanosuspension-Loaded Trilayer Dissolving Microneedle Patches for the Treatment of Psoriasis: In Vitro Delivery and In Vivo Antipsoriatic Activity Studies.
    Dai X; Permana AD; Li M; Habibie ; Nur Amir M; Peng K; Zhang C; Dai H; Paredes AJ; Vora LK; Donnelly RF
    Mol Pharm; 2024 Jun; 21(6):2813-2827. PubMed ID: 38752564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview.
    Dadwal A; Mishra N; Narang RK
    Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
    Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I
    Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanodelivery Systems for Topical Management of Skin Disorders.
    Cui M; Wiraja C; Chew SWT; Xu C
    Mol Pharm; 2021 Feb; 18(2):491-505. PubMed ID: 32470311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
    Shaif M; Kushwaha P; Usmani S; Pandey S
    J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development of tazarotene-loaded PLGA nanoparticles for follicular delivery in the treatment of inflammatory skin diseases.
    Kshirsagar SM; Shrestha N; Kipping T; Banga AK
    Eur J Pharm Biopharm; 2024 Jul; 200():114346. PubMed ID: 38823541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can nanoparticle-based technologies revolutionize the topical therapy in psoriasis?
    Sindrilaru A; Filip A; Scharffetter-Kochanek K; Crisan D
    Exp Dermatol; 2020 Nov; 29(11):1097-1103. PubMed ID: 32657487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment.
    Kahraman E; Aydilek N; Güngör S
    Recent Pat Drug Deliv Formul; 2020; 14(3):191-200. PubMed ID: 32819264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
    Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G
    AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.
    Martins AM; Ascenso A; Ribeiro HM; Marto J
    Mol Neurobiol; 2020 May; 57(5):2391-2419. PubMed ID: 32062841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.